Precision BioSciences reports positive Phase 1 hepatitis B trial data showing viral DNA elimination
Filed May 27, 2026 · Period ending May 27, 2026 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade DTIL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 27, 2026 9:45 PM